Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
LATEST IN Mayo Clinic
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
UMSL Business offers new Leadership Launchpad online course for young professionals starting in September
The online course targeted toward helping young professionals grow their leadership skills meets on Thursdays during the lunch hour.
UMSL community gathers to celebrate research excellence at annual Research and Innovation Reception
Faculty members Mary Edwin, Emily Brown, Anita Manion, Rachel Winograd, Vivek Singh and Michael Nichols were honored at Friday’s event in the Millennium Student Center.
UMSL community gathers to celebrate research excellence at annual Research and Innovation Reception
Faculty members Mary Edwin, Emily Brown, Anita Manion, Rachel Winograd, Vivek Singh and Michael Nichols were honored at Friday’s event in the Millennium Student Center.
UMSL community gathers to celebrate research excellence at annual Research and Innovation Reception
Faculty members Mary Edwin, Emily Brown, Anita Manion, Rachel Winograd, Vivek Singh and Michael Nichols were honored at Friday’s event in the Millennium Student Center.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
MORE IN Mayo Clinic
LATEST NEWS
- UMSL Business offers new Leadership Launchpad online course for young professionals starting in September
- UMSL appoints Marisa Smith to serve as new chief of police
- Retiring UMSL Police Chief Dan Freet awarded Chancellor’s Medal
- Eye on UMSL: Making connections
- As CEO of the National Student Nurses’ Association, UMSL alum Kenya Williams supports the next generation of nursing leaders
- Students connect across campus during first week of the fall semester
- Tonya and Tyler Haynes serve as ambassadors for Autism Speaks
- New school year starts by honoring faculty, staff with Chancellor’s Awards at State of the University Address
- Chancellor Kristin Sobolik highlights ways UMSL is positioning itself for the future during annual State of the University Address
- Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
